Bausch Health Cos Inc: Financial Update and Acquisition News
Bausch Health Companies Inc., a prominent player in the health care sector specializing in pharmaceuticals, has recently experienced significant market activity. The company, which focuses on developing drugs for central nervous system disorders, eye health, and gastrointestinal diseases, also offers a range of products including contact lenses and ophthalmic surgical equipment. Bausch Health is traded on the Toronto Stock Exchange and serves a global customer base.
Stock Market Performance
On August 12, 2025, Bausch Health’s stock (BHC) saw a notable rebound, increasing by 15.8%. This surge was attributed to bargain-hunting by investors, as reported by both Insider Monkey and Yahoo Finance. The close price of Bausch Health’s stock on August 11, 2025, was CAD 9.63, with a 52-week high of CAD 13.74 on November 5, 2024, and a 52-week low of CAD 5.91 on April 10, 2025. The company’s market capitalization stands at CAD 2.21 billion, with a price-to-earnings ratio of 27.572.
Acquisition of DURECT Corporation
In a significant business development, Bausch Health announced its acquisition of DURECT Corporation. The transaction, expected to close in the third quarter of 2025, involves Bausch Health paying $1.75 per share of DURECT common stock in an all-cash deal, amounting to an upfront consideration of approximately $63 million. Additionally, there is potential for up to $350 million in aggregate sales milestone payments, contingent on achieving specific sales targets related to larsucosterol in the United States before the earlier of the 10-year anniversary of its first commercial sale or December 31, 2045.
This acquisition is part of Bausch Health’s strategy to expand its portfolio and enhance its capabilities in the pharmaceutical industry. DURECT, a company based in Cupertino, California, will continue as a wholly owned subsidiary of Bausch Health following the merger.
These developments highlight Bausch Health’s active engagement in strategic growth initiatives and its responsiveness to market opportunities, positioning it as a dynamic player in the global health care sector.